Tobias Welte - Profile and Journalist Details
Find journalists that align with your industry, location and vision. Unlock Tobias Welte's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.
Get connected with journalists today
Tobias Welte
Verified
Associate Editor, Respiratory Medicine
Hanover
Beats
and anything wellness. sleep vitaminsMental health
non-fiction
Content
Anti-interleukin-5/anti-interleukin-5 receptor α treatment improves self-reported work productivity in patients with severe eosinophilic asthma: a prospective cohort trial
By Jan Fuge, Tobias Welte, Lina Brinkmann| ersnet.org@ IntroductionBronchial asthma is a common respiratory disease leading to symptoms such as coughing, wheezing, shortness of breath and chest tightness, and thereby affects millions of people worldwide in their daily life [1]. Approximately 3–10% of asthma patients have severe asthma, representing a heterogenous group of patients in which symptoms are not controlled by inhaled medication [2].
By Thomas Fuehner, Tobias Welte, Jan Schmieszek, Isabelle Renger| Wiley Online Library Verified Introduction The Seraph 100 Microbind Affinity blood filter eliminate bacteria, viruses, fungi and toxins from blood stream. Methods This is a prospective multicenter observational biomarker trial in PCR-positive SARS-CoV-2 patients with acute respiratory failure. Biomarkers were sequentially tested at three time points. Results Forty-two patients with SARS-CoV-2 detected by PCR with acute respiratory failure were included.
Anti-interleukin-5/anti-interleukin-5 receptor α treatment improves self-reported work productivity in patients with severe eosinophilic asthma: a prospective cohort trial
By Jan Fuge, Tobias Welte, Lina Brinkmann| ersnet.org@ IntroductionBronchial asthma is a common respiratory disease leading to symptoms such as coughing, wheezing, shortness of breath and chest tightness, and thereby affects millions of people worldwide in their daily life [1]. Approximately 3–10% of asthma patients have severe asthma, representing a heterogenous group of patients in which symptoms are not controlled by inhaled medication [2].
Company Info
Respiratory Medicine
Hanover, Lower Saxony, Germany
+49 511 5325550